OmniaBio News and Resources

The Government of Canada is continuing its efforts to strengthen the country’s life sciences and biomanufacturing sector. Since March 2020, over $2.3 billion has been invested in rebuilding Canada’s capacity for vaccines, therapeutics, and biomanufacturing. As part of this initiative, OmniaBio will

OmniaBio Inc., a contract development and manufacturing organisation (CDMO) specialising in cell and gene therapy (CGT), has announced the opening of its new manufacturing and AI centre of excellence in Hamilton, Ontario. The facility is now the largest of its

Somite Therapeutics, a tech-bio company specialising in AI-driven cell replacement therapies, has announced a collaboration with OmniaBio Inc., a CDMO focused on cell and gene therapies, to produce its flagship program for Duchenne muscular dystrophy (DMD). The partnership centres on